Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT
- PMID: 17925855
- PMCID: PMC1994593
- DOI: 10.1371/journal.pone.0001007
Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT
Abstract
Background: Traditional imaging techniques for the localization and monitoring of bacterial infections, although reasonably sensitive, suffer from a lack of specificity. This is particularly true for musculoskeletal infections. Bacteria possess a thymidine kinase (TK) whose substrate specificity is distinct from that of the major human TK. The substrate specificity difference has been exploited to develop a new imaging technique that can detect the presence of viable bacteria.
Methodology/principal findings: Eight subjects with suspected musculoskeletal infections and one healthy control were studied by a combination of [(124)I]FIAU-positron emission tomography and CT ([(124)I]FIAU-PET/CT). All patients with proven musculoskeletal infections demonstrated positive [(124)I]FIAU-PET/CT signals in the sites of concern at two hours after radiopharmaceutical administration. No adverse reactions with FIAU were observed.
Conclusions/significance: [(124)I]FIAU-PET/CT is a promising new method for imaging bacterial infections.
Conflict of interest statement
Figures

Similar articles
-
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [124I]FIAU PET/CT.Mol Imaging. 2020 Jan-Dec;19:1536012120936876. doi: 10.1177/1536012120936876. Mol Imaging. 2020. PMID: 32598214 Free PMC article.
-
The use of 14C-FIAU to predict bacterial thymidine kinase presence: implications for radiolabeled FIAU bacterial imaging.Nucl Med Biol. 2013 Jul;40(5):638-42. doi: 10.1016/j.nucmedbio.2013.01.005. Epub 2013 Mar 27. Nucl Med Biol. 2013. PMID: 23541824 Free PMC article.
-
[(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection.Nucl Med Biol. 2016 May;43(5):273-9. doi: 10.1016/j.nucmedbio.2016.01.004. Epub 2016 Feb 2. Nucl Med Biol. 2016. PMID: 27150029 Clinical Trial.
-
Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy.Q J Nucl Med. 1999 Jun;43(2):163-9. Q J Nucl Med. 1999. PMID: 10429512 Review.
-
Nuclear medicine imaging of bone infections.Clin Radiol. 2016 Jul;71(7):632-46. doi: 10.1016/j.crad.2016.01.003. Epub 2016 Feb 17. Clin Radiol. 2016. PMID: 26897336 Review.
Cited by
-
Engineered live bacteria as disease detection and diagnosis tools.J Biol Eng. 2023 Oct 24;17(1):65. doi: 10.1186/s13036-023-00379-z. J Biol Eng. 2023. PMID: 37875910 Free PMC article. Review.
-
Pathogen-Specific Bacterial Imaging in Nuclear Medicine.Semin Nucl Med. 2018 Mar;48(2):182-194. doi: 10.1053/j.semnuclmed.2017.11.003. Epub 2017 Dec 14. Semin Nucl Med. 2018. PMID: 29452620 Free PMC article. Review.
-
Specific Imaging of Bacterial Infection Using 6″-18F-Fluoromaltotriose: A Second-Generation PET Tracer Targeting the Maltodextrin Transporter in Bacteria.J Nucl Med. 2017 Oct;58(10):1679-1684. doi: 10.2967/jnumed.117.191452. Epub 2017 May 10. J Nucl Med. 2017. PMID: 28490473 Free PMC article.
-
Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics.Pharmaceutics. 2020 Dec 21;12(12):1247. doi: 10.3390/pharmaceutics12121247. Pharmaceutics. 2020. PMID: 33371500 Free PMC article. Review.
-
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [124I]FIAU PET/CT.Mol Imaging. 2020 Jan-Dec;19:1536012120936876. doi: 10.1177/1536012120936876. Mol Imaging. 2020. PMID: 32598214 Free PMC article.
References
-
- Becker W, Meller J. The role of nuclear medicine in infection and inflammation. The Lancet Infectious Diseases. 2001;1:326–333. - PubMed
-
- Love C, Palestro CJ. Radionuclide Imaging of Infection. J Nucl Med Technol. 2004;32:47–57. - PubMed
-
- Benitez A, Roca M, Martin-Comin J. Labeling of antibiotics for infection diagnosis. Q J Nucl Med Mol Imaging. 2006;50:147–152. - PubMed
-
- Sarda L, Cremieux A-C, Lebellec Y, Meulemans A, Lebtahi R, et al. Inability of 99mTc-Ciprofloxacin Scintigraphy to Discriminate Between Septic and Sterile Osteoarticular Diseases. J Nucl Med. 2003;44:920–926. - PubMed
-
- Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, et al. Antimicrobial Peptide 99mTc-Ubiquicidin 29-41 as Human Infection-Imaging Agent: Clinical Trial. J Nucl Med. 2005;46:567–573. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical